BP Buys Stake in Synthetic Genomics as Part of Bioenergy Deal to Study Hydrocarbon Flora | GenomeWeb
NEW YORK (GenomeWeb News) — Synthetic Genomics has formed a “long-term” research and development partnership with petroleum firm BP to identify alternative energy sources from subsurface hydrocarbons, Synthetic Genomics said today.
 
Synthetic Genomics also said the oil company has made an undisclosed equity investment in the privately held biotech, and that the two companies intend to jointly commercialize technologies developed under the partnership.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.